# Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients

> **NCT04684498** · PHASE4 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 382 (estimated)

## Conditions studied

- ST Elevation Myocardial Infarction
- STEMI

## Interventions

- **DRUG:** Oseltamivir phosphate capsules

## Key facts

- **NCT ID:** NCT04684498
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-03-31
- **Target enrollment:** 382 (ESTIMATED)
- **Last updated:** 2020-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04684498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04684498, "Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04684498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*